<SEC-DOCUMENT>0001193125-23-151964.txt : 20230524
<SEC-HEADER>0001193125-23-151964.hdr.sgml : 20230524
<ACCEPTANCE-DATETIME>20230523173709
ACCESSION NUMBER:		0001193125-23-151964
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20230524
DATE AS OF CHANGE:		20230523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ecovyst Inc.
		CENTRAL INDEX KEY:			0001708035
		STANDARD INDUSTRIAL CLASSIFICATION:	CHEMICALS & ALLIED PRODUCTS [2800]
		IRS NUMBER:				813406833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-255514
		FILM NUMBER:		23949973

	BUSINESS ADDRESS:	
		STREET 1:		300 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-617-1200

	MAIL ADDRESS:	
		STREET 1:		300 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PQ Group Holdings Inc.
		DATE OF NAME CHANGE:	20170531
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d491404d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(7) <BR>Registration File No. 333-255514 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information in this preliminary prospectus supplement is not
complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these
securities, and we are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>Subject to completion, dated May 23, 2023 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement to Prospectus dated April&nbsp;26, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>14,000,000 Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g491404g01m56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Ecovyst Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder named
in this prospectus supplement is offering 14,000,000 shares of our common stock. We will not receive any proceeds from the sale of our common stock by the selling stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the completion of this offering, we have agreed to purchase from the underwriter 4,000,000 shares of our common stock that are subject to this
offering at a price per share equal to the price per share paid by the underwriter to the selling stockholder in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is
listed on the New York Stock Exchange under the symbol &#147;ECVT.&#148; On May 22, 2023, the last sale price of our common stock as reported on the New York Stock Exchange was $11.39 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B><I>Investing in our common stock involves substantial risk. Please read &#147;<A HREF="#srom491404_5">Risk Factors</A>&#148; beginning on page S-4.
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
underwriter has agreed to purchase shares of our common stock from the selling stockholder at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which will result in approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of proceeds to the selling stockholder before expenses. The underwriter may offer the shares of common stock from time to time for sale in one or more transactions on the New York Stock Exchange, in
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices
or at negotiated prices, subject to receipt and acceptance by it and subject to its right to reject any order in whole or in part. We have agreed to reimburse the underwriter for certain expenses in connection with this offering. See
&#147;Underwriting&#148; beginning on page <FONT STYLE="white-space:nowrap">S-15.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder has granted the underwriter an option
for a period of up to 30 days from the date of this prospectus supplement to purchase up to an additional 2,100,000 shares of our common stock at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriter expects to deliver the shares against payment in New York, New York on or about
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>J.P. Morgan
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Prospectus supplement dated&nbsp;&nbsp;&nbsp;&nbsp;, 2023 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_2">TRADEMARKS AND TRADENAMES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_3">SUPPLY SHARE AND INDUSTRY INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_4">PROSPECTUS SUPPLEMENT SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_5">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_6">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_8">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_9">SELLING STOCKHOLDER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_10">MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_11">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_14">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#srom491404_15">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_2">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_4">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_5">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_6">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_7">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_8">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_9">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_10">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>None of the Company, the selling stockholder or the underwriter have authorized anyone to provide any information or to
make any representations other than those contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus or in any free writing prospectuses we have prepared. None of the Company, the selling stockholder or
the underwriter take any responsibility for, or can provide any assurance as to the reliability of, any other information that others may give you. This prospectus supplement and the accompanying prospectus are an offer to sell only the shares
offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus supplement and the accompanying prospectus is current only as of the date of the applicable document.
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Unless otherwise indicated or the context otherwise requires, references in this prospectus supplement to the &#147;Company,&#148; &#147;ECVT,&#148;
&#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Ecovyst Inc. and its consolidated subsidiaries. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first
part is this prospectus supplement, which describes the specific terms of this common stock offering and certain other matters relating to us, our business and prospects. The second part, the accompanying prospectus, contains a description of our
common stock and certain other information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this prospectus supplement may add, update or change information contained in
the accompanying prospectus or in documents that we file or have filed with the Securities and Exchange Commission (the &#147;SEC&#148;). To the extent the information contained in this prospectus supplement differs or varies from the information
contained in the accompanying prospectus or documents incorporated by reference filed before the date of this prospectus supplement, the information in this prospectus supplement will supersede such information. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_2"></A>TRADEMARKS AND TRADENAMES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own or have rights to trademarks or trade names that we use in conjunction with the operation of our business. In addition, our name, logo and website name
and address are our service marks or trademarks. Each trademark, trade name or service mark by any other company appearing in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference herein and therein
belongs to its holder. Some of the more important trade names and trademarks that we use include Ecovyst, Ecoservices, Catalyst Technologies, Zeolyst, and Zeolyst International. We also own or have the rights to copyrights that protect the content
of our products. Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in this prospectus supplement, the accompanying prospectus and in the documents incorporated by reference herein and therein are listed
without the TM, SM, <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and <SUP STYLE="font-size:75%; vertical-align:top">&copy;</SUP> symbols, but we will assert, to the fullest extent under applicable law, our rights to these trademarks,
service marks, trade names and copyrights. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_3"></A>SUPPLY SHARE AND INDUSTRY INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain statistical information used throughout this prospectus supplement and in the documents incorporated by reference herein is based on independent
industry publications, reports by research firms or other published independent sources. Some statistical information is also based on our good faith estimates, which are derived from management&#146;s knowledge of our industry and such independent
sources referred to above. Certain supply share statistics, ranking and industry information included in this prospectus supplement and in the documents incorporated by reference herein, including the size of certain markets and our estimated supply
share position and the supply share positions of our competitors, are based on management estimates. These estimates have been derived from our management&#146;s knowledge and experience in the industry and end uses into which we sell our products,
as well as information obtained from surveys, reports by research firms, our customers, distributors, suppliers, trade and business organizations and other contacts in the industries into which we sell our products. We believe these data to be
accurate as of the date of this prospectus supplement. However, this information may prove to be inaccurate because this information cannot always be verified with complete certainty due to the limitations on the availability and reliability of raw
data, the voluntary nature of the data gathering process and other limitations and uncertainties. Unless otherwise noted, all of our supply share position information presented in this prospectus supplement and in the documents incorporated by
reference herein is an approximation based on management&#146;s knowledge and is based on our, or, in the case of our zeolite catalysts product group, our Zeolyst Joint Venture&#146;s, sales volumes relative to the estimated sales volumes for the
year ended December&nbsp;31, 2022 in relevant products or end uses into which we sell our products. In the case of our Ecoservices segment, including the products and services thereof, such supply share position information excludes volume
attributable to manufacturers who produce primarily for their own consumption. References to our being a leader in a supply </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
share position or product group refer to our belief that we have one of the leading supply share positions, unless otherwise indicated or the context otherwise requires. In addition, references
to various end uses into which we sell our products are based on how we define the end uses for our products. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_4"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights information appearing elsewhere or incorporated by reference in this prospectus supplement and the accompanying prospectus. This
summary is not complete and does not contain all of the information that you should consider before investing in our common stock. You should carefully read the entire prospectus supplement, the accompanying prospectus and the financial data and
related notes and other information incorporated by reference in this prospectus supplement and the accompanying prospectus before deciding whether to invest in our common stock. All information in this prospectus supplement assumes no exercise of
the underwriter&#146;s option to purchase additional shares, unless otherwise noted. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a leading integrated and innovative global provider of specialty catalysts and services. We believe that our products, which are predominantly
inorganic, and services contribute to improving the sustainability of the environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conduct operations through two reporting segments:
(1)&nbsp;Ecoservices and (2)&nbsp;Catalyst Technologies (including our 50% interest in the Zeolyst Joint Venture). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ecoservices: We are a leading provider
of sulfuric acid recycling services to North American refineries for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency
standards. We are also a leading North American producer of <FONT STYLE="white-space:nowrap">on-purpose</FONT> virgin sulfuric acid for water treatment, mining and industrial applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Catalyst Technologies: We are a global supplier of finished silica catalysts and catalyst supports necessary to produce high strength and high stiffness
plastics used in packaging films, bottles, containers and other molded applications. This segment includes our 50% interest in the Zeolyst Joint Venture, where we are a leading global supplier of zeolites used for catalysts that help produce
renewable fuels and remove nitrogen oxides from diesel engine emissions as well as sulfur from fuels during the refining process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe we are a
leader in each of our business segments, holding what we estimate to be a number one or number two supply share position for products that generated more than 90% of our 2022 sales and our proportionate 50% share of sales attributable to the Zeolyst
Joint Venture, respectively. We believe that our global footprint and efficient network of strategically located manufacturing facilities provide us with a strong competitive advantage in serving our customers both regionally as well as globally.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe our long history of established customer relationships and our reputation for providing reliable and high quality products and services
enables us to deliver significant value to our customers, as demonstrated by our profit margins. Although our products and services typically constitute a small portion of our customers&#146; overall
<FONT STYLE="white-space:nowrap">end-product</FONT> costs, we believe they are critical to product performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a long track record of innovation
that is reflected in our technical and production expertise in silica, zeolites and catalyst technologies. We are highly diversified by business, geography and end use. In 2022, the majority of our sales were for applications that have historically
had relatively predictable, consistent demand patterns driven by consumption or frequent replacement cycles. We believe our strong commercial contract structure and the secular trends supporting our business segments have generally allowed us to
maintain stable margins through changing macro economic cycles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are focused on implementing and accelerating sustainability initiatives and supporting
the production of low carbon technologies. We believe our commitment to innovation is how we differentiate ourselves in the marketplace. We have the ability to tailor our products and services for the changing needs of our customers and
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
support them in addressing their technical and operational challenges. Through close collaboration with our global customers, we have been long standing suppliers of products and services that we
believe support sustainability, addressing tightening global regulatory standards and changing consumer preferences. For example, we continue to develop products that improve air quality through lower sulfur content in fuels and capturing nitrogen
oxide emissions from heavy duty vehicles. We are focused on catalyst innovation that enables stronger and lighter plastics and zeolites that can facilitate more efficient recycling of mixed plastics. Our sulfuric acid recycling is critical to the
production of alkylate for improved fuel economy and our catalyst products support the novel technologies that transform biomass into biofuels and synthetic rubber for green tires. We segment our projects into distinct development themes that we
believe are core to our sustainability efforts. With greater focus and resources, Ecovyst has historically expanded and accelerated the commercialization of its portfolio of sustainable products and solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2022, we served global customers across many end uses and, as of December&nbsp;31, 2022, operated out of ten strategically located manufacturing
facilities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Share Repurchase </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
intend to purchase from the underwriter 4,000,000 shares of our common stock that are subject to this offering at a price per share equal to the price per share paid by the underwriter to the selling stockholder in this offering. We refer to this
repurchase as the &#147;Share Repurchase.&#148; The Share Repurchase is part of our existing $450&nbsp;million common stock repurchase program approved by our board of directors on April&nbsp;27, 2022, which became effective immediately. After
giving effect to the Share Repurchase, we will have remaining authorization to repurchase up to approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million of our common stock under the repurchase program. We intend to fund the Share
Repurchase with cash on hand and cash generated from operations. The closing of the Share Repurchase is contingent on the closing of this offering. The Share Repurchase was approved by a special committee of our board of directors, which is
comprised entirely of disinterested directors. Any future stock repurchase under the common stock repurchase program can be subject to a 1% excise tax under the Inflation Reduction Act of 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The description and the other information in this prospectus supplement regarding the Share Repurchase is included in this prospectus supplement solely for
informational purposes. Nothing in this prospectus supplement should be construed as an offer to sell, or the solicitation of an offer to buy, any of our common stock subject to the Share Repurchase. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate Information </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our principal
executive offices are located at 300 Lindenwood Drive, Malvern, Pennsylvania 19355, and our telephone number is (484) <FONT STYLE="white-space:nowrap">617-1200.</FONT> Our Internet website address is www.ecovyst.com. The information on, or that can
be accessed through, our website is not part of this prospectus supplement or the accompanying prospectus, and you should not rely on any such information in making the decision whether to purchase our common stock. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by the selling stockholder </P></TD>
<TD>14,000,000 shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Option to purchase additional shares </P></TD>
<TD>The selling stockholder has granted the underwriter a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to 2,100,000 additional shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We will not receive any of the proceeds from the sale of shares of common stock by the selling stockholder. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Share Repurchase </P></TD>
<TD>Subject to completion of this offering, we have agreed to repurchase 4,000,000 shares of our common stock that are subject to this offering from the underwriter at a price per share equal to the price paid by the underwriter to the selling
stockholder in this offering. The closing of the Share Repurchase is contingent on the closing of this offering. The Share Repurchase was approved by a special committee of our board of directors, which is comprised entirely of disinterested
directors. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should read carefully the information set forth under &#147;Risk Factors&#148; herein and in the accompanying prospectus for a discussion of factors that you should consider before deciding to invest in our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">New York Stock Exchange trading symbol </P></TD>
<TD>&#147;ECVT&#148; </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>An investment in our common stock involves various risks. You should carefully consider the following risks and all of the other information contained in
this prospectus supplement and the accompanying prospectus before investing in our common stock. In addition, you should read and consider the risk factors associated with our business included in the documents incorporated by reference in this
prospectus supplement, including our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, and our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended
March&nbsp;31, 2023. See &#147;Where You Can Find More Information.&#148; The risks described below and incorporated herein by reference are those which we believe are the material risks that we face. The trading price of our common stock could
decline due to any of these risks, and you may lose all or part of your investment in our common stock. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Related to Our Common
Stock and this Offering </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>INEOS continues to have significant influence over us, which could limit your ability to influence the outcome of key
transactions, including a change of control. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering and the Share Repurchase, based on the 120,161,142 shares of
common stock outstanding as of May&nbsp;2, 2023, which, after giving effect to the Share Repurchase, will result in 116,161,142 shares of common stock outstanding, INEOS Limited, a privately owned corporation (&#147;INEOS&#148;), will beneficially
own approximately 9.2% of our outstanding common stock (or approximately 7.4% if the underwriter exercises its option to purchase additional shares in full). For as long as INEOS continues to beneficially own a substantial percentage of the voting
power of our outstanding common stock, it will continue to have significant influence over us. For example, INEOS will be able to strongly influence the election of all of the members of our board of directors and our business and affairs, including
any determinations with respect to mergers or other business combinations, the acquisition or disposition of assets, the incurrence of additional indebtedness, the issuance of any additional shares of common stock or other equity securities, the
repurchase or redemption of shares of our common stock and the payment of dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, INEOS may acquire and hold interests in businesses
that compete directly or indirectly with us, or may pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price could be extremely volatile and, as a result, you may not be able to resell your shares at or above the price you paid for them.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2022, the price of our common stock, as reported on the New York Stock Exchange, has ranged from an intraday low of $8.20 on
November&nbsp;15, 2022 to an intraday high of $12.05 on March&nbsp;29, 2022. In addition, the stock market in general has been highly volatile. As a result, the market price of our common stock is likely to be similarly volatile, and investors in
our common stock may experience a decrease, which could be substantial, in the value of their stock, including decreases unrelated to our operating performance or prospects, and could lose part or all of their investment. The price of our common
stock could be subject to wide fluctuations in response to a number of factors, including those described elsewhere herein and others such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in our operating performance and the performance of our competitors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated fluctuations in our quarterly or annual operating results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publication of research reports by securities analysts about us, our competitors or our industry;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure or the failure of our competitors to meet analysts&#146; projections or guidance that we or our
competitors may give to the market; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or departures of key personnel; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures,
strategic investments or changes in business strategy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the passage of legislation or other regulatory developments affecting us or our industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in legislation, regulation and government policy as a result of the U.S. presidential and congressional
elections; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">speculation in the press or investment community; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in accounting principles; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terrorist acts, acts of war or periods of widespread civil unrest; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">natural disasters and other calamities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in general market and economic conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance, and
factors beyond our control may cause our stock price to decline rapidly and unexpectedly. We are exposed to the impacts of any global or domestic economic disruption that may occur, including any impacts resulting from the war in Ukraine and the
economic effects of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the past, securities class action litigation has often been initiated against
companies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert our management&#146;s attention and resources, and could also require us to make substantial payments to satisfy
judgments or to settle litigation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Your percentage ownership in us may be diluted by future issuances of capital stock, which could reduce your
influence over matters on which stockholders vote. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has the authority, without action or vote of our stockholders, to issue
all or any part of our authorized but unissued shares of common stock, including shares issuable upon exercise of options, or shares of our authorized but unissued preferred stock, subject to the applicable rules of the New York Stock Exchange.
Issuances of common stock or voting preferred stock would reduce your influence over matters on which our stockholders vote and, in the case of issuances of preferred stock, would likely result in your interest in us being subject to the prior
rights of holders of that preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There may be sales of a substantial amount of our common stock after this offering by our current
stockholders, and these sales could cause the price of our common stock to fall. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of May&nbsp;2, 2023, there were 120,161,142 shares of our
common stock outstanding. Of our issued and outstanding shares, all of the common stock sold in our initial public offering, prior public offerings by our stockholders, or in this offering will be freely transferable, except for any shares held by
our &#147;affiliates,&#148; as that term is defined in Rule 144 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). Following completion of this offering and the Share Repurchase, which will result in 116,161,142 shares of
common stock outstanding, approximately 9.2% of our outstanding common stock (or approximately 7.4% if the underwriter exercises its option to purchase additional shares in full) will be held by INEOS. Sales of substantial amounts of our common
stock in the public market after this offering, or the perception that such sales will occur, could adversely affect the market price of our common stock and make it difficult for us to raise funds through securities offerings in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this offering, we, each of our officers and directors and INEOS have entered into a <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreement with the underwriter, which restricts their sales of our common stock for a period of 30 days after the date of this prospectus supplement, subject to certain exceptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we have registered shares of our common stock that are reserved for issuance under our 2016
Stock Incentive Plan and 2017 Omnibus Incentive Plan, as amended and restated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provisions in our charter documents and Delaware law may deter
takeover efforts that may be beneficial to stockholder value. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to INEOS&#146;s beneficial ownership of a substantial percentage of our
common stock, provisions in our certificate of incorporation and bylaws and Delaware law could make it harder for a third party to acquire us, even if doing so might be beneficial to our stockholders. These provisions include a classified board of
directors and the ability of our board of directors to issue preferred stock without stockholder approval that could be used to dilute a potential hostile acquiror. Our certificate of incorporation imposes some restrictions on mergers and other
business combinations between us and any holder of 15% or more of our outstanding common stock other than INEOS and investment funds affiliated with CCMP Capital Advisors, L.P., one of our former stockholders. As a result, you may lose your ability
to sell your stock for a price in excess of the prevailing market price due to these protective measures, and efforts by stockholders to change the direction or management of the company may be unsuccessful. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our certificate of incorporation designates courts in the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings
that may be initiated by our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides that, subject to limited exceptions, the Court of Chancery of the State of Delaware is the sole and exclusive forum
for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any derivative action or proceeding brought on our behalf; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other
employees to us or our stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any action asserting a claim against us arising pursuant to any provision of the General Corporation Law of the
State of Delaware, our certificate of incorporation or our bylaws; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any action to interpret, apply, enforce or determine the validity of our certificate of incorporation or bylaws;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other action asserting a claim against us that is governed by the internal affairs doctrine (each, a
&#147;Covered Proceeding&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our certificate of incorporation provides that if any action the subject matter of which
is a Covered Proceeding is filed in a court other than the specified Delaware courts without the approval of our board of directors (each, a &#147;Foreign Action&#148;), the claiming party will be deemed to have consented to (i)&nbsp;the personal
jurisdiction of the specified Delaware courts in connection with any action brought in any such courts to enforce the exclusive forum provision described above and (ii)&nbsp;having service of process made upon such claiming party in any such
enforcement action by service upon such claiming party&#146;s counsel in the Foreign Action as agent for such claiming party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any person or entity
purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and to have consented to these provisions. These provisions may limit a stockholder&#146;s ability to bring a claim in a judicial forum
that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our
certificate of incorporation inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could
adversely affect our business and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our certificate of incorporation contains a provision renouncing our interest and expectancy in
certain corporate opportunities, which could adversely impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INEOS, and the member of our board of directors who is affiliated with
INEOS, by the terms of our certificate of incorporation, are not required to offer us any corporate opportunity of which they become aware and can take any such corporate opportunity for themselves or offer it to other companies in which they have
an investment. We, by the terms of our certificate of incorporation, expressly renounce any interest or expectancy in any such corporate opportunity to the extent permitted under applicable law, even if the opportunity is one that we or our
subsidiaries might reasonably have pursued or had the ability or desire to pursue if granted the opportunity to do so. Our certificate of incorporation may not be amended to eliminate our renunciation of any such corporate opportunity arising prior
to the date of any such amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">INEOS may from time to time acquire and hold interests in businesses that compete directly or indirectly with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These potential conflicts of interest could have a material adverse effect on our business, financial condition, results of operations or prospects if INEOS
allocates attractive corporate opportunities to itself or its affiliates instead of to us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not pay additional dividends on our common stock
and, consequentially, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we paid special cash dividends in December 2020 and August 2021, our board of directors may decide to retain future earnings, if any, for future
operations, expansion and debt repayment and may not pay any special or regular dividends for the foreseeable future. Any decision to declare and pay special or regular dividends in the future will be made at the discretion of our board of directors
and will depend on, among other things, our results of operations, financial condition, cash requirements, contractual restrictions and other factors that our board of directors may deem relevant. In addition, our ability to pay dividends may be
limited by covenants of any existing and future outstanding indebtedness we or our subsidiaries incur, including our credit facilities and outstanding notes. As a result, you may not receive any return on an investment in our common stock unless you
sell your common stock for a price greater than that which you paid for it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_6"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein include statements that express our
opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, &#147;forward-looking statements.&#148; These forward-looking statements can
generally be identified by the use of forward-looking terminology, including the terms &#147;believes,&#148; &#147;expects,&#148; &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;seeks,&#148; &#147;projects,&#148;
&#147;approximately,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;estimates&#148; or &#147;anticipates,&#148; or, in each case, their negatives or other variations or comparable terminology. These forward-looking statements include all
matters that are not historical facts. They appear in a number of places throughout this prospectus supplement, the accompanying prospectus and the documents incorporated herein and therein by reference and include, but are not limited to,
statements regarding our future results of operations, financial condition, liquidity, prospects, growth, strategies, capital allocation program, product and service offerings, including the impact of Russia&#146;s invasion of Ukraine on such items,
expected demand trends and our 2023 financial outlook. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By their nature, forward-looking statements involve risks and uncertainties because they relate to
events and depend on circumstances that may or may not occur in the future. Some of the key factors that could cause actual results to differ from our expectations include the following risks related to our business: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as a global business, we are exposed to local business risks in different countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are affected by general economic conditions and economic downturns; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exchange rate fluctuations could adversely affect our financial condition, results of operations and cash flows;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our international operations require us to comply with anti-corruption laws, trade and export controls and
regulations of the U.S. government and various international jurisdictions in which we do business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">alternative technology or other changes in our customers&#146; products may reduce or eliminate the need for
certain of our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our new product development and research and development efforts may not succeed and our competitors may develop
more effective or successful products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our substantial level of indebtedness could adversely affect our financial condition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we are unable to manage the current and future inflationary environment and to pass on increases in raw
material prices, including natural gas, or labor costs to our customers or to retain or replace our key suppliers, our results of operations and cash flows may be negatively affected; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we face substantial competition in the industries in which we operate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are subject to the risk of loss resulting from <FONT STYLE="white-space:nowrap">non-payment</FONT> or <FONT
STYLE="white-space:nowrap">non-performance</FONT> by our customers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we rely on a limited number of customers for a meaningful portion of our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">multi-year customer contracts in our Ecoservices segment are subject to potential early termination and such
contracts may not be renewed at the end of their respective terms; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our quarterly results of operations are subject to fluctuations because the demand for some of our products is
seasonal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our growth projects may result in significant expenditures before generating revenues, if any, which may
materially and adversely affect our ability to implement our business strategy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be liable to damages based on product liability claims brought against us or our customers for costs
associated with recalls of our or our customers&#146; products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are subject to extensive environmental, health and safety regulations and face various risks associated with
potential <FONT STYLE="white-space:nowrap">non-compliance</FONT> or releases of hazardous materials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">existing and proposed regulations to address climate change by limiting greenhouse gas emissions may cause us to
incur significant additional operating and capital expenses and may impact our business and results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">production and distribution of our products could be disrupted for a variety of reasons, including as a result of
supply chain constraints, and such disruptions could expose us to significant losses or liabilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the insurance that we maintain may not fully cover all potential exposures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we could be subject to damages based on claims brought against us by our customers or lose customers as a result
of the failure of our products to meet certain quality specifications; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to protect our intellectual property and infringement on the intellectual property rights of third
parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruption, failure or cyber security breaches affecting or targeting computers and infrastructure used by us or
our business partners may adversely impact our business and operations; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the global economy and financial
markets, as well as on our business and our suppliers, and the response of governments and of our company to the outbreak including variants of the virus and associated containment, remediation and vaccination efforts. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The above is not a complete list of factors that could cause actual results to differ from our expectations, and it is not possible for us to predict all of
them. Important factors that could cause actual results to differ materially from our expectations are more fully described in our other filings with the SEC, including in the &#147;Risk Factors&#148; section in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, and our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2023, incorporated by reference in this prospectus
supplement. See &#147;Where You Can Find More Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we base these forward-looking statements on assumptions that we believe are
reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may
differ materially from those made in or suggested by the forward-looking statements contained in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein. In addition, even if our results
of operations, financial condition and liquidity, and the development of the industry in which we operate, are consistent with the forward-looking statements, those results or developments may not be indicative of results or developments in
subsequent periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Any
forward-looking statement that we make in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein speaks only as of the date of such statement, and we undertake no obligation to update
any forward-looking statements or to publicly announce the results of any revisions to any of those statements to reflect future events or developments, except as required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of shares of our common stock by the selling stockholder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_8"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we paid a special cash dividend of $1.80 per share on December&nbsp;29, 2020 and a special cash dividend of $3.20 per share on August&nbsp;23, 2021,
each of which were financed with the net proceeds from the sale of our Performance Materials business and our Performance Chemicals business, respectively, we may retain future earnings, if any, for future operations, expansion and debt repayment
and may not pay any special or regular dividends for the foreseeable future. Any decision to declare and pay special or regular dividends in the future will be made at the discretion of our board of directors and will depend on, among other things,
our results of operations, financial condition, cash requirements, contractual restrictions and other factors that our board of directors may deem relevant. In addition, our ability to pay dividends may be limited by covenants of any existing and
future outstanding indebtedness we or our subsidiaries incur, including our credit facilities and outstanding notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_9"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table and footnotes set forth information with respect to the beneficial ownership of our common stock as of May&nbsp;2, 2023 by the selling
stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The percentage ownership information shown in the table below with respect to the shares of common stock owned before this offering is based
upon 120,161,142 shares of common stock outstanding as of May&nbsp;2, 2023. The percentage ownership information shown in the table below with respect to shares owned after this offering is based upon 116,161,142 shares of common stock outstanding,
which gives effect to the Share Repurchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or
investment power with respect to the shares. Except as indicated in the footnote to this table, we believe that the selling stockholder identified in the table below possesses sole voting and investment power over all shares shown as beneficially
owned by such selling stockholder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Owned Before the<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Offered<BR>Hereby&nbsp;(no</B><br><B>option<BR>exercise)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;Owned&nbsp;After&nbsp;the<BR>Offering&nbsp;(no&nbsp;option&nbsp;exercise)&nbsp;<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>

<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INEOS Limited<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,731,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.6%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,731,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes the consummation of the Share Repurchase of 4,000,000 shares of our common stock from the underwriter
concurrently with the closing of this offering. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shareholders of INEOS Limited are James A. Ratcliffe, John Reece and Andrew Currie. Mr.&nbsp;Ratcliffe, as
the majority owner of INEOS Limited, has the power to control the voting and disposition of the shares of our common stock held by INEOS Limited. Jonny Ginns, a director for multiple INEOS Limited entities, serves as a director of the Company. The
operating address of INEOS Limited is 38 Hans Cres, Knightsbridge, London SW1X 0LZ, United Kingdom. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_10"></A>MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS FOR
<FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF COMMON STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material U.S. federal income and estate
tax considerations relating to the purchase, ownership and disposition of our common stock by <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders (defined below). This summary does not purport to be a complete analysis of all the potential tax
considerations relevant to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders. This summary is based upon the Internal Revenue Code of 1986, as amended (the &#147;Internal Revenue Code&#148;), the Treasury regulations promulgated or proposed
thereunder and administrative and judicial interpretations thereof, all as of the date hereof and all of which are subject to change at any time, possibly on a retroactive basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary assumes that shares of our common stock are held as &#147;capital assets&#148; within the meaning of Section&nbsp;1221 of the Internal Revenue
Code. This summary does not purport to deal with all aspects of U.S. federal income and estate taxation that might be relevant to particular <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders in light of their particular investment
circumstances or status, nor does it address specific tax considerations that may be relevant to particular persons (including, for example, financial institutions, broker-dealers, taxpayers subject to special tax accounting rules under
Section&nbsp;451(b) of the Internal Revenue Code, insurance companies, partnerships or other pass-through entities, certain U.S. expatriates, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations, pension plans, &#147;controlled foreign
corporations&#148;, &#147;passive foreign investment companies&#148;, corporations that accumulate earnings to avoid U.S. federal income tax, persons in special situations, such as those who have elected to mark securities to market or those who
hold common stock as part of a straddle, hedge, conversion transaction, synthetic security or other integrated investment, or holders subject to the alternative minimum tax). In addition, except as explicitly addressed herein with respect to estate
tax, this summary does not address estate and gift tax considerations, the Medicare contribution tax on net investment income, or considerations under the tax laws of any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this summary, a <FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> Holder&#148; means a beneficial owner of common stock that for
U.S. federal income tax purposes is not classified as a partnership and that, for U.S. federal income tax purposes, is not: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation or any other organization taxable as a corporation for U.S. federal income tax purposes, created or
organized in or under the laws of the United States, any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is included in gross income for U.S. federal income tax purposes regardless of its
source; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if (1)&nbsp;a U.S. court is able to exercise primary supervision over the trust&#146;s administration and
one or more U.S. persons have the authority to control all of the trust&#146;s substantial decisions or (2)&nbsp;the trust has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an entity that is classified as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of
persons treated as its partners for U.S. federal income tax purposes will generally depend upon the status of the partner and the activities of the partnership. Partnerships and other entities that are classified as partnerships for U.S. federal
income tax purposes and persons holding our common stock through a partnership or other entity classified as a partnership for U.S. federal income tax purposes are urged to consult their own tax advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Internal Revenue Service (&#147;IRS&#148;) will not challenge one or more of the tax consequences described herein, and we
have not obtained, nor do we intend to obtain a ruling from the IRS with respect to the U.S. federal income or estate tax consequences to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder of the purchase, ownership or disposition of our
common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS SUMMARY IS FOR GENERAL INFORMATION ONLY AND IS NOT INTENDED TO BE TAX ADVICE. <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS ARE URGED TO CONSULT THEIR TAX ADVISORS CONCERNING THE U.S. FEDERAL INCOME AND ESTATE TAXATION, STATE, LOCAL AND <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAXATION AND OTHER TAX CONSEQUENCES
TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Distributions on Our Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed under &#147;Dividend Policy&#148; above, we may retain future earnings, if any, for future operations, expansion and debt repayment and may not
pay any special or regular dividends for the foreseeable future. However, we expect to reevaluate our dividend policy on a regular basis following this offering and may, subject to compliance with the covenants contained in our senior secured credit
facilities and other considerations, determine to pay dividends in the future. In the event that we make a distribution of cash or property with respect to our common stock, any such distributions generally will constitute dividends for U.S. federal
income tax purposes to the extent of our current and accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will constitute a
return of capital and will first reduce the holder&#146;s adjusted tax basis in our common stock, but not below zero. Any remaining excess will be treated as capital gain, subject to the tax treatment described below in &#147;&#151;Gain on Sale,
Exchange or Other Taxable Disposition of Our Common Stock.&#148; Any such distribution would also be subject to the discussions below under the sections titled &#147;&#151;Additional Withholding and Reporting Requirements&#148; and
&#147;&#151;Backup Withholding and Information Reporting.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder generally
will be subject to a 30% U.S. federal withholding tax unless such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder provides us or the applicable withholding agent, as the case may be, with the appropriate IRS Form <FONT
STYLE="white-space:nowrap">W-8,</FONT> such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or successor forms) certifying, under penalties of perjury, a reduction in, or exemption from, withholding under an applicable income tax treaty, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> (or successor form) certifying, under penalties of
perjury, that a dividend paid on common stock is not subject to withholding tax because it is effectively connected with a trade or business in the United States of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder (in which case such
dividend generally will be subject to regular graduated U.S. tax rates as described below). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The certification requirement described
above must be provided to us or the applicable withholding agent prior to the payment of dividends and may be required to be updated periodically. The certification also may require a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that
provides an IRS form or that claims treaty benefits to provide its U.S. taxpayer identification number. Special certification and other requirements apply in the case of certain <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders that hold
shares of our common stock through intermediaries or are pass-through entities for U.S. federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is urged to consult its own tax advisor about the specific methods for satisfying these requirements. A claim for exemption will not be valid if the person receiving the applicable form has
actual knowledge or reason to know that the statements on the form are false. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If dividends are effectively connected with a trade or business in the
United States of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder (and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment), the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder,
although exempt from the withholding tax described above (provided that the certification requirements described above are satisfied), generally will be subject to U.S. federal income tax on such dividends on a net income basis in the same manner as
if it were a United States person, as defined under the Internal Revenue Code. In addition, if a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is treated as a corporation for U.S. federal income tax purposes, the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder may be subject to an additional &#147;branch profits tax&#148; equal to 30% (unless reduced by an applicable income treaty) of its earnings and profits in respect of such effectively connected
dividend income. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders that do not timely provide us or the applicable
withholding agent with the required certification, but which are eligible for a reduced rate of U.S. federal withholding tax pursuant to an income tax treaty, may obtain a refund or credit of any excess amount withheld by timely filing an
appropriate claim for refund with the IRS. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Gain on Sale, Exchange or Other Taxable Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussions below under the sections titled &#147;&#151;Additional Withholding and Reporting Requirements&#148; and &#147;&#151;Backup
Withholding and Information Reporting&#148;, in general, a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will not be subject to U.S. federal income tax or withholding tax on gain realized upon such holder&#146;s sale, exchange or other
taxable disposition of shares of our common stock unless (i)&nbsp;such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is an individual who is present in the United States for 183 days or more in the taxable year of disposition, and certain
other conditions are met, (ii)&nbsp;we are or have been a &#147;United States real property holding corporation&#148;, as defined in the Internal Revenue Code (a &#147;USRPHC&#148;), at any time within the shorter of the five-year period preceding
the disposition and the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s holding period in the shares of our common stock, and certain other requirements are met, or (iii)&nbsp;such gain is effectively connected with the conduct by
such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder of a trade or business in the United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment maintained by such <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder in the United States). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the first exception applies, the
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder generally will be subject to U.S. federal income tax at a rate of 30% (or at a reduced rate under an applicable income tax treaty) on the amount by which such
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s capital gains allocable to U.S. sources exceed capital losses allocable to U.S. sources during the taxable year of the disposition. If the third exception applies, the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder generally will be subject to U.S. federal income tax with respect to such gain on a net income basis in the same manner as if it were a resident of the United States and a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is a corporation for U.S. federal income tax purposes may also be subject to a branch profits tax with respect to any earnings and profits attributable to such gain at a rate of 30% (or at a
reduced rate under an applicable income tax treaty). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, a corporation is a USRPHC only if the fair market value of its United States real
property interests (as defined in the Internal Revenue Code) equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be
no assurance in this regard, we believe that we are not, and do not anticipate becoming, a USRPHC. However, because the determination of whether we are a USRPHC depends on the fair market value of our United States real property interests relative
to the fair market value of other business assets, there can be no assurance that we will not become a USRPHC in the future. Even if we are or were to become a USRPHC, a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder would not be subject to
U.S. federal income tax on a sale, exchange or other taxable disposition of our common stock by reason of our status as USRPHC so long as our common stock is &#147;regularly traded&#148; (as defined by applicable Treasury regulations) on an
established securities market at any time during the calendar year in which the disposition occurs and such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder does not own and is not deemed to own (directly, indirectly or constructively) more
than 5% of our common stock at any time during the shorter of the five-year period ending on the date of disposition and the holder&#146;s holding period. However, no assurance can be provided that our common stock will be regularly traded on an
established securities market for purposes of the rules described above. Prospective investors are encouraged to consult their own tax advisors regarding the possible consequences to them if we are, or were to become, a USRPHC. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Additional Withholding and Reporting Requirements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Internal Revenue Code and the related Treasury regulations, together with other U.S. Treasury and IRS guidance issued
thereunder and intergovernmental agreements, legislation, rules and other official guidance adopted pursuant to such intergovernmental agreements (collectively, &#147;FATCA&#148;) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
generally impose U.S. federal withholding at a rate of 30% on payments of dividends on our common stock on certain <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities (including certain
intermediaries) unless such persons establish that they are compliant with or exempt from FATCA. This regime requires, among other things, a broad class of persons to enter into agreements with the IRS to obtain, disclose and report information
about their investors and account holders. An intergovernmental agreement between the U.S. and an applicable foreign country may, however, modify these requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the applicable Treasury regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on shares of our
common stock to such applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities that fail to establish they are compliant with or exempt from FATCA. While withholding under FATCA would have also applied to payments of gross proceeds from
the sale or other disposition of stock on or after January&nbsp;1, 2019 by such applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities, proposed Treasury regulations (on which taxpayers may currently rely) eliminate FATCA withholding
on payments of gross proceeds from the sale or other disposition of stock entirely. Taxpayers generally may rely on these proposed Treasury regulations until final Treasury regulations are issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prospective investors should consult their own tax advisors regarding the possible impact of these rules on their investment in our common stock, and the
entities through which they hold our common stock, including, without limitation, the process and deadlines for meeting the applicable requirements to prevent the imposition of this 30% withholding tax under FATCA. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Backup Withholding and Information Reporting </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, information reporting will apply to distributions on our common stock paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder and the
tax withheld, if any, with respect to the distributions. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders may have to comply with specific certification procedures to establish that the holder is not a United States person (as defined in the
Internal Revenue Code) in order to avoid backup withholding at the applicable rate, currently 24%, with respect to dividends on our common stock. Dividends paid to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders subject to the U.S.
withholding tax, as described above under the section titled &#147;&#151;Distributions on Our Common Stock,&#148; generally will be exempt from U.S. backup withholding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information reporting and, depending on the circumstances, backup withholding will generally apply to the proceeds of a disposition of our common stock by a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder and satisfies certain other
requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder where the transaction is
effected outside the United States through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, for information reporting purposes, dispositions effected through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of
a U.S. broker or a foreign broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. Prospective investors should consult their own tax advisors
regarding the application of the information reporting and backup withholding rules to them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of information returns may be made available to the
tax authorities of the country in which the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder resides or in which the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is incorporated, under the provisions of a specific treaty or
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder may be refunded or credited against the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s U.S. federal income tax liability, if any, provided that an appropriate claim is timely filed
with the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Federal Estate Tax </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares of our common stock that are owned (or treated as owned) by an individual who is not a citizen or resident of the United States (as specially defined
for U.S. federal estate tax purposes) at the time of death will be included in such individual&#146;s gross estate for U.S. federal estate tax purposes, unless an applicable estate or other tax treaty provides otherwise, and therefore may be subject
to U.S. federal estate tax. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_11"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC is acting as the underwriter in connection with this offering. Subject to the terms and conditions set forth in an underwriting
agreement among the Company, the selling stockholder and the underwriter, the underwriter has agreed to purchase, and the selling stockholder has agreed to sell to such underwriter, 14,000,000 shares of common stock at a price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which will result in $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of proceeds to the selling stockholder before expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the obligations of the underwriter to purchase the shares included in this offering are subject to approval of legal
matters by counsel and to other conditions. The underwriter is obligated to purchase all the shares (other than those covered by the underwriter&#146;s option to purchase additional shares described below) if the underwriter purchases any of the
shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the completion of this offering, we have agreed to purchase 4,000,000 shares of our common stock that are subject to this offering
from the underwriter at a price per share equal to the price per share paid by the underwriter to the selling stockholder in this offering. The closing of the Share Repurchase is contingent on the closing of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder has granted to the underwriter an option, exercisable for 30 days from the date of this prospectus supplement, to purchase up to
2,100,000 additional shares at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. Any shares issued or sold under the option will be issued and sold on the same terms and conditions as the other shares that are the subject of
this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, our officers and directors and the selling stockholder have agreed that, for a period of 30 days from the date of this prospectus
supplement, we and they will not, without the prior written consent of the underwriter, dispose of or hedge any shares or any securities convertible into or exchangeable for our common stock, subject to certain exceptions. The underwriter, in its
sole discretion, may release any of the securities subject to these <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements at any time without notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares are listed on the New York Stock Exchange under the symbol &#147;ECVT.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriter may receive from purchasers of the shares normal brokerage commissions in amounts agreed with such purchasers. The underwriter may offer the
shares of common stock for sale from time to time in one or more transactions on the New York Stock Exchange, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, through negotiated
transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices, subject to receipt and acceptance by the underwriter and subject to its right to reject any order in
whole or in part. The underwriter may effect such transactions by selling shares of common stock to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriter and/or
purchasers of shares of common stock for whom they may act as agents or to whom they may sell as principals. The difference between the price at which the underwriter purchases shares of common stock and the price at which the underwriter resells
such shares of common stock may be deemed underwriting compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The expenses of the offering, including expenses incurred by the selling
stockholder, are estimated at $750,000 and are payable by us. We have agreed to reimburse the underwriter for expenses relating to clearance of this offering with the Financial Industry Regulatory Authority up to $25,000. The underwriter has agreed
to reimburse us for certain expenses incurred in connection with the offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriter may purchase and sell shares in the open market. Purchases
and sales in the open market may include short sales, purchases to cover short positions, which may include purchases pursuant to the underwriter&#146;s option to purchase additional shares, and stabilizing purchases. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Short sales involve secondary market sales by the underwriter of a greater number of shares than they are
required to purchase in the offering, and a short position represents the amount of such sales that have not been covered by subsequent purchases. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Covered&#148; short sales are sales of shares in an amount up to the number of shares represented by the
underwriter&#146;s option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Naked&#148; short sales are sales of shares in an amount in excess of the number of shares represented by
the underwriter&#146;s option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Covering transactions involve purchases of shares either pursuant to the underwriter&#146;s option to purchase
additional shares or in the open market in order to cover short positions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To close a naked short position, the underwriter must purchase shares in the open market. A naked short position
is more likely to be created if the underwriter is concerned that there may be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To close a covered short position, the underwriter must purchase shares in the open market or must exercise the
option to purchase additional shares. In determining the source of shares to close the covered short position, the underwriter will consider, among other things, the price of shares available for purchase in the open market as compared to the price
at which they may purchase shares through the underwriter&#146;s option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stabilizing transactions involve bids to purchase shares so long as the stabilizing bids do not exceed a
specified maximum. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchases to cover short positions and stabilizing purchases, as well as other purchases by the underwriter for its
own account, may have the effect of preventing or retarding a decline in the market price of the shares. They may also cause the price of the shares to be higher than the price that would otherwise exist in the open market in the absence of these
transactions. The underwriter may conduct these transactions on the New York Stock Exchange, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. If the underwriter commences
any of these transactions, it may discontinue them at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriter is a full service financial institution engaged in various activities, which may include securities trading, commercial and investment banking,
financial advisory, investment management, principal investment, hedging, financing and brokerage activities. The underwriter and its affiliates have in the past performed commercial banking, investment banking and advisory services for us from time
to time for which they have received customary fees and reimbursement of expenses and may, from time to time, engage in transactions with and perform services for us in the ordinary course of their business for which they may receive customary fees
and reimbursement of expenses. In the ordinary course of their various business activities, the underwriter and its affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative
securities) and financial instruments (which may include bank loans and/or credit default swaps) for the underwriter&#146;s own account and for the accounts of its customers and may at any time hold long and short positions in such securities and
instruments. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriter and its affiliates may also make investment recommendations and/or publish or express independent research
views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriter against certain liabilities, including liabilities under the
Securities Act, or to contribute to payments the underwriter may be required to make because of any of those liabilities. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in the European Economic Area </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In relation to each EEA Member State (each a &#147;Relevant Member State&#148;), no shares have been offered or will be offered pursuant to this offering to
the public in that Relevant Member State prior to the publication of a prospectus in relation to such shares which has been approved by the competent authority in that Relevant Member State or, where appropriate, approved in another Relevant Member
State and notified to the competent authority in that Relevant Member State, all in accordance with the Prospectus Regulation, except that such shares may be offered to the public in that Relevant Member State at any time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the
Prospectus Regulation) subject to obtaining the prior consent of the underwriter for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require the issuer and/or selling stockholder or the underwriter to publish a prospectus pursuant to Article 3 of
the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the
expression an &#147;offer to the public&#148; in relation to the shares described in this prospectus in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the shares
to be offered so as to enable an investor to decide to purchase any shares, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each person in a Relevant Member State who receives any communication in respect of, or who acquires any shares under, the offering contemplated hereby will
be deemed to have represented, warranted and agreed to and with the underwriter and its affiliates and the issuer that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it is a qualified investor within the meaning of the Prospectus Regulation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any shares described in this prospectus acquired by it as a financial intermediary, as that term
is used in Article 5 of the Prospectus Regulation, (i)&nbsp;such shares acquired by it in this offering have not been acquired on a <FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf of, nor have they been acquired with a view
to their offer or resale to, persons in any Relevant Member State other than qualified investors, as that term is defined in the Prospectus Regulation, or have been acquired in other circumstances falling within the points (a)&nbsp;to (d) of Article
1(4) of the Prospectus Regulation and the prior consent of the underwriter has been given to the offer or resale; or (ii)&nbsp;where such shares have been acquired by it on behalf of persons in any Relevant Member State other than qualified
investors, the offer of those shares to it is not treated under the Prospectus Regulation as having been made to such persons. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
issuer, the underwriter and its affiliates, and others will rely upon the truth and accuracy of the foregoing representation, acknowledgement and agreement. Notwithstanding the above, a person who is not a qualified investor and who has notified the
underwriter of such fact in writing may, with the prior consent of the underwriter, be permitted to acquire shares in this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to
Prospective Investors in the United Kingdom </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any other material in relation to the shares described herein is only being
distributed to, and is only directed at, and any investment or investment activity to which this Prospectus relates is available only to, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and will be engaged in only with, persons who are (i)&nbsp;persons having professional experience in matters relating to investments who fall within the definition of investment professionals in
Article 19(5) of the Financial Promotion Order (the &#147;FPO&#148;); (ii) high net worth entities falling within Article 49(2)(a) to (d)&nbsp;of the FPO; (iii)&nbsp;outside the United Kingdom; or (iv)&nbsp;persons to whom an invitation or
inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000 (the &#147;FSMA&#148;)) in connection with the issue or sale of any shares may otherwise lawfully be communicated or
caused to be communicated, (all such persons together being referred to as &#147;Relevant Persons&#148;). The shares described in this prospectus are only available in the United Kingdom to, and any invitation, offer or agreement to purchase or
otherwise acquire the shares will be engaged in only with, the Relevant Persons. This prospectus and its contents are confidential and should not be distributed, published or reproduced (in whole or in part) or disclosed by recipients to any other
person in the United Kingdom. Any person in the United Kingdom that is not a Relevant Person should not act or rely on this prospectus or any of its contents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in
relation to the shares which has been approved by the Financial Conduct Authority, except that the shares may be offered to the public in the United Kingdom at any time: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK
Prospectus Regulation), subject to obtaining the prior consent of the underwriter for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Section&nbsp;86 of the FSMA; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of the shares shall require the issuer and/or the underwriter or any of its affiliates to publish a prospectus pursuant to
Section&nbsp;85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to the shares in the United Kingdom
means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares and the expression &#147;UK
Prospectus Regulation&#148; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each
person in the United Kingdom who acquires any shares in this offering or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the issuer, the underwriter and its affiliates that it meets the criteria
outlined in this section. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Canada </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument
<FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument <FONT STYLE="white-space:nowrap">31-103</FONT> Registration
Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
supplement or the accompanying prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities
legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal
advisor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT>
<I>Underwriting Conflicts</I> (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriter is not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of
interest in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in France </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither this prospectus nor any other offering material relating to the shares described in this prospectus has been submitted to the clearance procedures of
the <I>Autorit&eacute; des March&eacute;s Financiers</I> or of the competent authority of another member state of the European Economic Area and notified to the <I>Autorit&eacute; des March&eacute;s Financiers</I>. The shares have not been offered
or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares has been or will be: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">released, issued, distributed or caused to be released, issued or distributed to the public in France; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">used in connection with any offer for subscription or sale of the shares to the public in France.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Such offers, sales and distributions will be made in France only: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to qualified investors (<I>investisseurs</I><I> </I><I>qualifi</I><I>&eacute;</I><I>s</I>) and/or to a restricted
circle of investors (<I>cercle</I><I> </I><I>restreint</I><I> </I><I>d</I><I>&#146;</I><I>investisseurs</I>), in each case investing for their own account, all as defined in, and in accordance with articles
<FONT STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">D.411-1,</FONT> <FONT STYLE="white-space:nowrap">D.411-2,</FONT> <FONT STYLE="white-space:nowrap">D.734-1,</FONT> <FONT STYLE="white-space:nowrap">D.744-1,</FONT> <FONT
STYLE="white-space:nowrap">D.754-1</FONT> and <FONT STYLE="white-space:nowrap">D.764-1</FONT> of the French Code mon&eacute;taire et financier; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to investment services providers authorized to engage in portfolio management on behalf of third parties; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a transaction that, in accordance with article
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.411-2-II-1&deg;</FONT></FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">-or-2&deg;</FONT></FONT> <FONT
STYLE="white-space:nowrap">-or</FONT> 3&deg; of the French <I>Code </I><I>mon</I><I>&eacute;</I><I>taire</I><I> et financier</I> and article <FONT STYLE="white-space:nowrap">211-2</FONT> of the General Regulations
(<I>R</I><I>&egrave;</I><I>glement</I><I> </I><I>G</I><I>&eacute;</I><I>n</I><I>&eacute;</I><I>ral</I><I>)</I> of the Autorit&eacute; des March&eacute;s Financiers, does not constitute a public offer (<I>appel</I><I> public </I><I>&agrave;</I><I>
</I><I>I</I><I>&#146;</I><I>&eacute;</I><I>pargne</I>). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may be resold directly or indirectly, only in compliance with
articles <FONT STYLE="white-space:nowrap">L.411-1,</FONT> <FONT STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">L.412-1</FONT> and <FONT STYLE="white-space:nowrap">L.621-8</FONT> through <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">L.621-8-3</FONT></FONT> of the French <I>Code mon&eacute;taire et financier</I>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Hong
Kong </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may not be offered or sold in Hong Kong by means of any document other than (i)&nbsp;in circumstances which do not constitute an offer
to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii)&nbsp;to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made
thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to
the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong
Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; within the meaning of the
Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Japan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares offered in this prospectus have not been and will not be registered under the Financial Instruments and Exchange Law of Japan. The shares have not
been offered or sold and will not be offered or sold, directly or indirectly, in Japan or to or for the account of any resident of Japan (including any corporation or other entity organized under the laws of Japan), except (i)&nbsp;pursuant to an
exemption from the registration requirements of the Financial Instruments and Exchange Law and (ii)&nbsp;in compliance with any other applicable requirements of Japanese law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Singapore </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or
material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or
purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#147;SFA&#148;), (ii) to a relevant person
pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other
applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where the shares are subscribed or purchased
under Section&nbsp;275 of the SFA by a relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business
of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, shares, debentures and units of shares and debentures of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be
transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to an institutional investor (for corporations, under Section&nbsp;274 of the SFA) or to a relevant person
defined in Section&nbsp;275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust are acquired at a
consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance with the
conditions specified in Section&nbsp;275 of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where no consideration is or will be given for the transfer; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where the transfer is by operation of law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Solely for the purposes of its obligations pursuant to section 30913(1)(a) and 30913(1)(c) of the SFA and the Securities and Futures (Capital Markets
Products) Regulations 2018 of Singapore (the &#147;CMP Regulations 2018&#148;), the issuer has determined, and hereby notifies all relevant persons (as defined in Section&nbsp;309A(1) of the SFA), that the shares are &#147;prescribed capital markets
products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products; and MAS notice <FONT
STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the issuance of the shares of common stock to be sold in this offering will be passed upon for us by Ropes&nbsp;&amp; Gray LLP. Certain legal
matters in connection with this offering will be passed upon for the underwriter by Latham&nbsp;&amp; Watkins LLP. Cravath, Swaine&nbsp;&amp; Moore LLP is acting as counsel to the selling stockholder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_13"></A>EXPERTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in Management&#146;s Annual Report on Internal Control over Financial Reporting) of Ecovyst Inc. incorporated
in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent
registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements of Zeolyst
International incorporated in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of Ecovyst Inc. for the year ended December&nbsp;31, 2022 have been so incorporated in reliance on the report (which
includes an emphasis of matter paragraph relating to the Zeolyst International&#146;s significant related party transactions as described in Footnote 15 to the financial statements) of PricewaterhouseCoopers LLP, an independent registered public
accounting firm, given on the authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_14"></A>WHERE YOU CAN
FIND MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities
Act with respect to the shares of our common stock being offered by this prospectus supplement and the accompanying prospectus. This prospectus supplement and the accompanying prospectus do not contain all of the information set forth in the
registration statement. For further information with respect to us and the shares of our common stock, reference is made to the registration statement and its exhibits. Statements contained in this prospectus supplement or the accompanying
prospectus as to the contents of any contract or other document are not necessarily complete. We are required to file annual, quarterly and current reports, proxy statements, and other information with the SEC. Such materials may be accessed
electronically by means of the SEC&#146;s website at www.sec.gov. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="srom491404_15"></A>INCORPORATION OF CERTAIN INFORMATION BY
REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus supplement information we file with it, which means that we
can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus supplement and information in documents that we file later with the SEC will
automatically update and supersede information in this prospectus supplement. We incorporate by reference into this prospectus supplement the documents listed below and any future filings made by us with the SEC under Section&nbsp;13(a), 13(c), 14
or 15(d) of the Securities Exchange Act of 1934, as amended, except for information &#147;furnished&#148; under Items 2.02, 7.01 or 9.01 on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or other information &#147;furnished&#148; to the SEC which
is not deemed filed and not incorporated in this prospectus supplement, until the termination of this offering. We hereby incorporate by reference the following documents: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000170803523000007/ecvt-20221231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2022, filed with the SEC on February 28, 2023; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">portions of our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000114036123018223/ny20007617x1_def14a.htm">Schedule
 14A</A>, filed with the SEC on April&nbsp;
13, 2023, that are incorporated by reference into Part III of our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000170803523000007/ecvt-20221231.htm">Form <FONT STYLE="white-space:nowrap">10-K
</FONT></A> for the year ended December&nbsp;31, 2022, filed with the SEC on February&nbsp;28, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended March&nbsp;31, 2023, filed
with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000170803523000013/ecvt-20230331.htm">May&nbsp;5, 2023</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (or amendment(s) thereto) as filed with
the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000119312523061422/d459991d8k.htm">March&nbsp;
6, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000119312523097954/d461672d8k.htm">April&nbsp;
11, 2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1708035/000170803523000017/ecvt-20230510.htm">May&nbsp;11, 2023</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in the Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000119312517298321/d451059d8a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A>, as filed with the SEC on September&nbsp;29, 2017, and any amendment or report filed with the SEC for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a copy of these filings, at no cost, by writing or telephoning us at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Ecovyst Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">300 Lindenwood Drive
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Malvern, PA 19355 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(484) <FONT
STYLE="white-space:nowrap">617-1200</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of these filings are also available, without charge, on the SEC&#146;s website at www.sec.gov and on
our website at www.ecovyst.com as soon as reasonably practicable after they are filed electronically with the SEC. The information contained on our website is not a part of this prospectus supplement or the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g491404g01v00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>PQ Group Holdings Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Common Stock </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders to be
named in a prospectus supplement may offer and sell shares of our common stock from time to time in amounts, at prices and on terms that will be determined at the time of the offering. We will not receive any proceeds from the sale of shares by the
selling stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus describes the general manner in which the shares of our common stock may be offered and sold by the selling
stockholders. The identity of, and specific information required with respect to, the selling stockholders, and the specific manner in which shares of our common stock may be offered and sold will be described in a supplement to this prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should carefully read this prospectus and any accompanying prospectus supplement, together with the documents we incorporate by reference, before you
invest in our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York Stock Exchange (the &#147;NYSE&#148;) under the symbol &#147;PQG.&#148; The last
reported sale of our common stock on the NYSE on April 23, 2021 was $16.66 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Investing in our common stock involves substantial risk.
Please read &#147;<A HREF="#cov175381_1">Risk Factors</A>&#148; beginning on page 2 of this prospectus and any risk factors described in any applicable prospectus supplement and in the documents we incorporate by reference. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Prospectus dated April&nbsp;26, 2021
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_2">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_4">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_5">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_6">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_7">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_8">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_9">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom175381_10">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>We have not authorized anyone to provide any information or to make any representations other than those contained or
incorporated by reference in this prospectus, any accompanying prospectus supplement or in any free writing prospectuses we have prepared. We take no responsibility for, and can provide no assurance as to the reliability of, any other information
that others may give you. This prospectus and any accompanying prospectus supplement are an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained or
incorporated by reference in this prospectus and any accompanying prospectus supplement is current only as of the date of the applicable document. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Unless otherwise stated in this prospectus or the context requires otherwise, references to &#147;we,&#148; &#147;our,&#148; &#147;us,&#148; &#147;PQ Group
Holdings Inc.&#148; and the &#147;Company&#148; and similar terms refer to PQ Group Holdings Inc. and its consolidated subsidiaries. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus
is part of a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> that we filed with the Securities and Exchange Commission (&#147;SEC&#148;) as a &#147;well-known seasoned issuer&#148; as defined under Rule 405 under the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), using a &#147;shelf&#148; registration process. Under this shelf registration process, the selling stockholders may from time to time sell shares of our common stock in one or more
offerings. This prospectus provides you with a general description of our common stock. Each time the selling stockholders sell shares of our common stock under this shelf registration, we will provide a prospectus supplement that will contain
specific information about the terms of that offering, including the specific amounts and prices of the shares of our common stock offered and information about the selling stockholders. The prospectus supplement may also add, update or change
information contained in this prospectus. Any statement that we make in this prospectus will be modified or superseded by any inconsistent statement made by us in a prospectus supplement. Before making your investment decision, you should read both
this prospectus and any prospectus supplement, including all documents incorporated herein or therein by reference, together with additional information described under &#147;Where You Can Find More Information.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_2"></A><A NAME="cov175381_1"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing in shares of our common stock involves a high degree of risk. See &#147;Item IA. Risk Factors&#148; in our most recent Annual Report on Form <FONT
STYLE="white-space:nowrap">I0-K</FONT> and in subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> which are incorporated by reference in this prospectus, and the &#147;Risk Factors&#148; section in the applicable
prospectus supplement for a discussion of the factors you should carefully consider before deciding to purchase shares of our common stock. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_3"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and any information incorporated by reference into this prospectus or such prospectus supplement may contain
certain &#147;forward-looking statements.&#148; You can generally identify these forward-looking statements by forward-looking words such as &#147;believe,&#148; &#147;anticipate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;plan,&#148;
&#147;will,&#148; &#147;may,&#148; &#147;estimate,&#148; &#147;could,&#148; &#147;continue,&#148; &#147;ongoing,&#148; &#147;predict,&#148; &#147;potential,&#148; &#147;likely,&#148; &#147;seek,&#148; and other similar expressions, as well as
variations or negatives of these words. You can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on current expectations and involve
inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes to differ materially from current expectations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements are not guarantees of future performance and our actual results could differ materially from the results discussed in the
forward-looking statements we make. In particular, you should consider the numerous risks described in the &#147;Risk Factors&#148; section of our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and in subsequent
Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> which are incorporated by reference in this prospectus, and the risk factors contained in any applicable prospectus supplement or free writing prospectus. See &#147;Where You
Can Find More Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of these and other factors, we may not actually achieve the plans, intentions or expectations disclosed in
our forward-looking statements, and you should not place undue reliance on our forward-looking statements. The forward-looking statements contained in this prospectus reflect our views as of the date hereof. We do not assume any obligation to update
any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_4"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of shares of our common stock by the selling stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_5"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of
450,000,000 shares of common stock, par value $0.01 per share, and 50,000,000 shares of undesignated preferred stock. The following summary describes all material provisions of our capital stock. We urge you to read our certificate of incorporation
and our bylaws, which are included as exhibits to the registration statement of which this prospectus forms a part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and
bylaws contain provisions that are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and which may have the effect of delaying, deferring or preventing a future takeover or change in control
of our company unless such takeover or change in control is approved by our board of directors. These provisions include a classified board of directors, elimination of the ability of stockholders to call special meetings, advance notice procedures
for stockholder proposals and the ability of our board of directors to issue preferred stock without stockholder approval that could be used to dilute a potential hostile acquiror. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, there were
136,318,557 shares of our common stock outstanding held of record by approximately 84 stockholders. Holders of our common stock are entitled to the following rights: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividend Rights</I>. Subject to preferences that may apply to shares of preferred stock outstanding at the time, holders of outstanding shares of our
common stock will be entitled to receive dividends out of assets legally available at the times and in the amounts as our board of directors may from time to time determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights</I>. Each outstanding share of our common stock is entitled to one vote on all matters submitted to a vote of stockholders. Holders of shares
of our common stock shall have no cumulative voting rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise required under the Delaware General Corporation Law or provided for in
our certificate of incorporation, all matters other than the election of directors are determined by a majority of the votes cast on the matter and all elections of directors are determined by a plurality of the votes cast. However, we have
implemented a Majority Voting Policy for uncontested director elections (elections in which the number of nominees for election does not exceed the number of directors to be elected). In the event that the votes &#147;withheld&#148; from a
nominee&#146;s election exceed the votes cast &#147;for&#148; that nominee&#146;s election, such nominee shall be required to submit his or her resignation to our board of directors for consideration. Our board of directors will then have the
opportunity to determine whether to accept or reject such tendered resignation. Our board of directors, in making its decision, may consider any factors or other information that it considers appropriate or relevant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors will act within 120 days following certification of the shareholder vote. Thereafter, our board of directors will promptly publicly
disclose, in a report furnished to the SEC, its decision regarding the tendered resignation, including its rationale for accepting or rejecting the tendered resignation. Our board of directors may accept a director&#146;s resignation or reject the
resignation. If our board of directors accepts a director&#146;s resignation, or if a nominee for director is not elected and the nominee is not an incumbent director, then our board of directors, in its sole discretion, may fill any resulting
vacancy or may decrease the size of our board of directors, in each case pursuant to our bylaws. If a director&#146;s resignation is not accepted by our board of directors, such director will continue to serve until the next annual meeting of
shareholders when such director&#146;s class is up for <FONT STYLE="white-space:nowrap">re-election</FONT> and until his or her successor is duly elected, or his or her earlier resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preemptive Rights</I>. Our common stock is not entitled to preemptive or other similar subscription rights to purchase any of our securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conversion or Redemption Rights</I>. Our common stock does not have any conversion rights and there are
no redemption or sinking fund provisions applicable to our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation Rights</I>. Upon our liquidation, the holders of our common stock
will be entitled to receive pro rata our assets that are legally available for distribution, after payment of all debts and other liabilities and subject to the prior rights of any holders of preferred stock then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Exchange Listing</I>. Our common stock is listed on the New York Stock Exchange under the symbol &#147;PQG.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors may, without
further action by our stockholders, from time to time, direct the issuance of shares of preferred stock in series and may, at the time of issuance, determine the designations, powers, preferences, privileges, and relative participating, optional or
special rights as well as the qualifications, limitations or restrictions thereof, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may be greater than the rights of
our common stock. Satisfaction of any dividend preferences of outstanding shares of preferred stock would reduce the amount of funds available for the payment of dividends on shares of our common stock. Holders of shares of preferred stock may be
entitled to receive a preference payment in the event of our liquidation before any payment is made to the holders of shares of our common stock. Under certain circumstances, the issuance of shares of preferred stock may render more difficult or
tend to discourage a merger, tender offer or proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management. Upon the affirmative vote of a majority of the total number of directors
then in office, our board of directors, without stockholder approval, may issue shares of preferred stock with voting and conversion rights which could adversely affect the holders of shares of our common stock and the market value of our common
stock. As of December&nbsp;31, 2020, there were no shares of preferred stock outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of our Certificate of Incorporation
and Bylaws </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws contain certain provisions that are intended to enhance the likelihood of continuity and
stability in the composition of our board of directors and which may have the effect of delaying, deferring or preventing a future takeover or change in control of the company unless such takeover or change in control is approved by our board of
directors. These provisions include: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Classified Board</I>. Our certificate of incorporation provides that our board of directors be divided into three
classes of directors, with the classes as nearly equal in number as possible. As a result, approximately <FONT STYLE="white-space:nowrap">one-third</FONT> of our board of directors is elected each year. The classification of directors has the effect
of making it more difficult for stockholders to change the composition of our board. Our certificate of incorporation also provides that, subject to any rights of holders of preferred stock to elect additional directors under specified
circumstances, the number of directors is fixed exclusively pursuant to a resolution adopted by our board of directors. Our board of directors currently has eleven members. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Special Meetings of Stockholders</I>. Our certificate of incorporation and bylaws provide that, except as otherwise required by law, special meetings of
the stockholders can only be called by the chairman of our board or pursuant to a resolution adopted by a majority of our board of directors. Except as otherwise required by law, stockholders are not permitted to call a special meeting or to require
our board of directors to call a special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Removal of Directors</I>. Our certificate of incorporation provides that our directors may be
removed only for cause by the affirmative vote of at least a majority of the voting power of our outstanding shares of capital stock entitled to vote generally in the election of directors, voting together as a single class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advance Notice Procedures</I>. Our bylaws establish an advance notice procedure for stockholder proposals
to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors. Stockholders at an annual meeting are only able to consider proposals or nominations specified in the
notice of meeting or brought before the meeting by or at the direction of our board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given our
Secretary timely written notice, in proper form, of the stockholder&#146;s intention to bring that business before the meeting. Although the bylaws do not give our board of directors the power to approve or disapprove stockholder nominations of
candidates or proposals regarding other business to be conducted at a special or annual meeting, the bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or
deter a potential acquiror from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of the company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized but Unissued Shares</I>. Our authorized but unissued shares of common stock and preferred stock are available for future issuance without
stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but
unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of a majority of our common stock by means of a proxy contest, tender offer, merger or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Business Combinations with Interested Stockholders</I>. We have elected in our certificate of incorporation not to be subject to Section&nbsp;203 of the
Delaware General Corporation Law, an antitakeover law. In general, Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging in a business combination, such as a merger, with a person or group owning 15% or more of the
corporation&#146;s voting stock for a period of three years following the date the person became an interested stockholder, unless (with certain exceptions) the business combination or the transaction in which the person became an interested
stockholder is approved in a prescribed manner. Accordingly, we are not subject to any anti-takeover effects of Section&nbsp;203. However, our certificate of incorporation contains provisions that have the same effect as Section&nbsp;203, except
that they provide that INEOS Limited (as a permitted transferee of INEOS Investments Partnership) (&#147;INEOS&#148;) and investment funds affiliated with CCMP Capital Advisors, LP (&#147;CCMP&#148;), and certain of their respective transferees and
affiliates will not be deemed to be &#147;interested stockholders,&#148; regardless of the percentage of our voting stock owned by them, and accordingly will not be subject to such restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exclusive Forum</I>. Our certificate of incorporation provides that, subject to limited exceptions, the Court of Chancery of the State of Delaware is the
sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our
stockholders, (iii)&nbsp;any action asserting a claim against us arising pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws, or (iv)&nbsp;any other action asserting a claim against us
that is governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and to have consented to the provisions of our certificate of
incorporation described above. Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of
discouraging lawsuits against our directors and officers. The enforceability of similar choice of forum provisions in other companies&#146; certificates of incorporation has been challenged in legal proceedings, and it is possible that, in
connection with one or more actions or proceedings described above, a court could find the choice of forum provisions contained in our certificate of incorporation to be inapplicable or unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Opportunities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides that we renounce any interest or expectancy of the company in the business opportunities of CCMP and INEOS and of
their respective officers, directors, agents, stockholders, members, partners, affiliates and subsidiaries and each such party shall not have any obligation to offer us those opportunities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification of Officers and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation limits the liability of our directors to the fullest extent permitted by the Delaware General Corporation Law or any other law
of the state of Delaware and our bylaws provide that we may indemnify our directors and our officers that are appointed by our board of directors to the fullest extent permitted by applicable law. We have entered into indemnification agreements with
our current directors and executive officers and expect to enter into similar agreements with any new directors or executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent
and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is American Stock Transfer and Trust Company, LLC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_6"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders may sell shares of our common stock in any of the ways described below or in any combination thereof: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters or dealers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through one or more agents; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to purchasers or to a single purchaser. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The distribution of shares of our common stock by the selling stockholders may be effected from time to time in one or more transactions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price, or prices, which may be changed from time to time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to such prevailing market prices; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time we offer and sell securities covered by this prospectus, we will make available a prospectus supplement or supplements. Each prospectus supplement
will describe the method of distribution of the shares of our common stock and any applicable restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each prospectus supplement will describe the
terms of the offering of shares of our common stock, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of any underwriters, dealers or agents and the number of shares of our common stock
underwritten or purchased by each of them; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if a fixed price offering, the public offering price of the shares of common stock and the proceeds to the
selling stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any discounts, commissions or concessions allowed or reallowed or paid to underwriters, dealers or agents, and
other items constituting underwriters&#146;, dealers&#146; or agents&#146; compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any options under which underwriters may purchase additional securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delayed delivery arrangements; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">information about the selling stockholders, including the relationship between the selling stockholders and us.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any offering price and any discounts or concessions allowed or reallowed or paid to dealers will be specified in the applicable
prospectus supplement and may be changed from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only the agents or underwriters named in each prospectus supplement will be agents or
underwriters in connection with the shares of our common stock being offered thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholders may authorize underwriters, dealers or
other persons acting as our agents to solicit offers by certain institutions to purchase securities from the selling stockholders pursuant to delayed delivery contracts providing for payment and delivery on the date stated in each applicable
prospectus supplement. Each contract will be for an amount not less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in each applicable prospectus supplement.
Institutions with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
institutions, but shall in all cases be subject to our approval. Delayed delivery contracts will be subject only to those conditions set forth in the applicable prospectus supplement, and the
applicable prospectus supplement will set forth any commissions we pay for solicitation of these contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agents, underwriters and other third parties
described above may be entitled to indemnification by us and the selling stockholders against certain civil liabilities, including liabilities under the Securities Act, or to contribution from us and the selling stockholders with respect to payments
which the agents, underwriters or third parties may be required to make in respect thereof. Agents, underwriters and such other third parties may be customers of, engage in transactions with, or perform services for us or the selling stockholders in
the ordinary course of business. We and the selling stockholders may also use underwriters or such other third parties with whom we or such selling stockholders have a material relationship. We and the selling stockholders will describe the nature
of any such relationship in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain underwriters may use this prospectus and any accompanying prospectus supplement
for offers and sales related to market-making transactions in shares of our common stock. These underwriters may act as principal or agent in these transactions, and the sales will be made at prices related to prevailing market prices at the time of
sale. Any underwriters involved in the sale of shares of our common stock may qualify as &#147;underwriters&#148; within the meaning of Section&nbsp;2(a)(11) of the Securities Act. In addition, the underwriters&#146; commissions, discounts or
concessions may qualify as underwriters&#146; compensation under the Securities Act and the rules of the Financial Industry Regulatory Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
common stock is listed on the New York Stock Exchange. Underwriters may make a market in shares of our common stock, but will not be obligated to do so and may discontinue any market making at any time without notice. We can make no assurance as to
the development, maintenance or liquidity of any trading market in shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain persons participating in an offering may engage in
overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with rules and regulations under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). Overallotment involves sales in
excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Short covering transactions involve purchases of
shares of our common stock in the open market after the distribution is completed to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the shares of our common stock originally sold by the
dealer are purchased in a covering transaction to cover short positions. Those activities may cause the price of shares of our common stock to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities
at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There can be no assurance that the selling stockholders will sell any of the shares of our common stock registered pursuant to the
registration statement of which this prospectus or any applicable prospectus supplement forms a part. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_7"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered hereby will be passed upon for us by Ropes&nbsp;&amp; Gray, LLP, Boston, Massachusetts. Certain legal
matters relating to the shares of our common stock offered hereby will be passed upon on behalf of the underwriter(s) by counsel that we will name in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_8"></A>EXPERTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in Management&#146;s Report on Internal Control over Financial Reporting) of PQ Group Holdings Inc.
incorporated in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2020 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an
independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements of
Zeolyst International incorporated in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2020 have been so incorporated in reliance on the report of
PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_9"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act with respect to the shares of
our common stock being offered by this prospectus. This prospectus, which forms a part of the registration statement, does not contain all of the information set forth in the registration statement. For further information with respect to us and the
shares of our common stock, reference is made to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or other document are not necessarily complete. We are required to file annual,
quarterly and current reports, proxy statements and other information with the SEC. Such materials may be accessed electronically by means of the SEC&#146;s website at <I>www.sec.gov</I>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom175381_10"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus information we file with it, which means that we can disclose important
information to you by referring to these documents. The information incorporated by reference is considered to be part of this prospectus and information in documents that we file later with the SEC will automatically update and supersede
information in this prospectus. We incorporate by reference into this prospectus the documents listed below and any future filings made by us with the SEC under Section&nbsp;13(a), 13(c), 14, or 15(d) of the Exchange Act, except for information
&#147;furnished&#148; under Items 2.02, 7.01, or 9.01 on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or other information &#147;furnished&#148; to the SEC which is not deemed filed and not incorporated in this prospectus, until the termination
of the offering of securities described in the applicable prospectus supplement. We hereby incorporate by reference the following documents: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000170803521000005/pqg-20201231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2020, filed with the SEC on March&nbsp;17, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portions of our Definitive Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000114036121011255/nc10018983x1_def14a.htm">Schedule
 14A</A>, filed with the SEC on April&nbsp;
1, 2021, that are incorporated by reference in our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000170803521000005/pqg-20201231.htm">Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended
December&nbsp;31, 2020; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000119312521069600/d335516d8k.htm">March&nbsp;4,
 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000119312521082857/d69322d8k.htm">March<U></U>&nbsp;16, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000119312521091244/d141313d8k.htm">March<U></U>&nbsp;
23, 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001708035/000119312521131499/d272209d8k.htm">April&nbsp;26, 2021</A>, excluding, in each case, information &#147;furnished&#148; pursuant to Items
2.02, 7.01 or 9.01; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in the Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1708035/000119312517298321/d451059d8a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT></A>, as filed with the SEC on September&nbsp;29, 2017, and any amendment or report filed with the SEC for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a copy of these filings, at no cost, by writing or telephoning us at: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PQ Group Holdings Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>300 Lindenwood Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Malvern, PA 19355 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Phone:
(610) <FONT STYLE="white-space:nowrap">651-4400</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the filings are also available, without charge on the SEC&#146;s website,
www.sec.gov, and on our website, https://www.pqcorp.com, as soon as reasonably practicable after they are filed electronically with the SEC. The information contained on our website is not a part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>14,000,000 Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Ecovyst Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common
Stock </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g491404g29m56.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus
Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>J.P. Morgan </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g491404g01m56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g491404g01m56.jpg
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M 0$! 0$! 0$! ?_  !$( "L D@,!$0 "$0$#$0'_Q  >  $  @(#  ,
M        " D&!P0%"@$" __$ "P0  $% 0 " @$# P4! 0    0! @,%!@<
M"!$2$PD4(146(Q<B05&Q\''_Q  = 0$  @(# 0$             !P@%!@(#
M! D!_\0 -Q$  @(" @(! @8! 00+     @,!! 4& !$'$A,4(0@5(B,Q05%A
M%B0RD24S-$)#4G%SDJ&Q_]H # ,!  (1 Q$ /P#W\>../'''CCCQQQXXX\<<
M>../'''CCCQQQXXX\<<>..1J]E_9O&>MF2BMKJ-UWJKI"(<ECQ)VPF6Y$#6_
MF,,G5LJUU($^2)#3UAFD5\L8P@Y!$GT9LNN:S;V%SB$QJX^F(G?OMB96D2[]
M5+'N/EL-@2^-?L,1 D;" ([F*?*WEG!>+<2FQ="<EG,G+%8/ H:*WWF+]898
M>R1/Z3'5I,/J+4K84D0J0IK2]1J"[)W?MQ(,&I[=K;&MNM(,VQPW <^49G*6
MIIBD5X6HZ15@$Q'RU?POY<]F]"8;>Z*55-LI:_.0,#N]AHZ31V*R<B+JVK4#
M(+-DF%%O-/7_ ,59;H@/1$]3%DT" #$_&'3)F>5(W3RGN]"JF_M^5,-DS*1L
MX'0Z!,HX[#T7Q,HRVPTTG\QJZGVQF-R;GW\@4_4621CE0JY":@=T+7:MQ>8_
MN>YV!TLAJSYY#WV_^-$=(3]JQ&R""AQM172M6$, >-/Y@'A;].W;\Q6JUEXW
M'UUJK(6-:G2K*B%J6 ^BEI2$?81B(@1B/Z_SR(=8I;!F,N5VLS)W<S9:=M]J
MJ;RN&WOW:\S1T:U)C[D?8*2$1]UK'J)V<A]WNL<(-$I>B[*/K]&R2."PS*VD
M&ENJ*)7HDT@W16S2BS&P1.CE'K8K#75DK(I*PB?.&*XF&*:N*V0;!V\DRK0Q
MLB1#3>LFWS*8*1D?C-851B?69^4G%(]C%<)F#&RFM^:\GII)QN4RA[@L)6%F
MJ%L+QT ]HADKS\DT++@7T:JZG9&J?H5<WT&^Q#>1SKHF2ZMCJ7=XBTCML]>#
M_F&G:GXR!YF.6,JOL!G*L@=B!.UXQ@LG^Z*9B_5TD3HY'^D2$X[$H*.YCN/\
MQ/4_Z_\ /EP,%G,;LF*J9G$V(LT;B_=9]>I@43TQ#US,RIZ3B5M7/W$HGJ2&
M1*<W\Y<R_'CCCQQQXXX\<<*J)\?*HGROPGS_ ,K_ -)_VO\ "^../''.*<<'
M6!&65B4.#7UXI!QYI4K(!0PQ(7D%%$SR*V.$<>"-\TTLCFLCC8Y[E1J*OG-:
MV.8M*@)C6F*U+ 9(V,,H$  8B9(C*8$1B)F9F(B.YYTV+"*J'VK+EUZU9++%
MA[C%:4(2!,:YK#F!6M:Q(S,I@1$9*9B(F>5P>KW9^S>SW=^D='K=+89_UBQI
MLV>R&72FI8TU]JT1!A2#;(JJDNXW_MI%U=L/!90+7S6&?J$9,.ICWRUN6O:_
MINLXC$NIJM;ED%C;OW)LV"_+T2<F8+2#XK3'O$4D&:3^456K'8'\<15WQ-OF
M\^6O(NT;-3RMG&^)L ]F,Q&*BC0C\\O0B%I-UIU(L@$PDOSFZI=I15F6<92B
M&**P4V4^1%RU''CCCQQR$/JE[K4OMAN.W9G)X&VHL[QN^CHDVAUV&<%KG&7.
MAK:HJM ' @>'&>%G";9T<AA3A82!89'/=*R5TA[IX^L:5CM>N7<FBQ:SU:;/
MY>NNQ3:,+KU6O!S#84'*F6@1W !!D!S$1ZS$0[XT\OTO)N;W'&8O"6JE#4;H
MTYS#K:G(RA.MWZ]8ZZ02!*AR:#+4B362L&*$NY*"F;W_ -_W_P">1YR8N52]
M"Y]M)NEW?4C,41U[V/T<C8^5<Z_% ?S_ (#D()969F^WMH7-#G/[B''5UD(
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M*1#52DI6BPHJJOXAQ8HOLJK]/E5\C3-VZM43BLE*8B)Z^( &9^W7WGJ)F?\
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KJ+'$8VO2EJ5RUH0;+#>Q@Y%EEQ,L&$%,D($R0&9_2,<W-YEN;#QXXY__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g491404g01v00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g491404g01v00.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[16Z4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %9Z^530X0DE-! 0      &$< 5H  QLE1QP"   "(  < E  "')R,S4Y
M,#DS' (% $!-:6-R;W-O9G0@5V]R9" M($%C=&EV95\Y,C<Q-S8Q,E\Q-E]0
M44<@+2!0<F5L:6UI;F%R>2!0<F]S<&5C='5S #A"24T$)0      $&&6*T4A
MJO_8@G1F&]N#,F8X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L  $         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    %HX0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              #)   #*@         !
M      $              RH   #)                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     @X0DE-! P     "Q(    !    H
M "@   '@  !+    "O8 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( "@ H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$!_\  $0@ 0 $# P$1  (1 0,1 ?_$ !\  0 !! (# 0
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M1J"@;]Q493^BZEPBW?)0'4$\7$;6CZ:#K)MIMFCZME3J32X*6S+O+O4Z4A1
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MB-QHS%9ZI7FKIY*I$=O54FQ#-T&;@2BH<H',4  0YYU%_ ^?UGY1R%M21=1
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MU"$((C]@ QA .1_+G2$?H @( (" @/N @/("'Y@(??2$!$ ^X@'/VY$ YTA
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M-LWP>7UGY=(V:?L'(C[!^\?;4Q1'@! ?<! 0_,!YTA'@#D$> ,41_(# (_W
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ML;')?9YV6:+UW7&52&K^"C-\+TQIZH-B6U*>%5U2B5BTM,2YL4F:E^)9;'W
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MC&$WOI".22M8K<ZQ2BYNOPDQ&H 0$8^4BV+]DB"90(F"35T@J@F!" !" 0@
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+#2$-(0TA#2$?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g491404g29m56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g491404g29m56.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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MU1%1L<3'R/=[-8USE1%_8B9F(C;>9B(WF!C>9V]D4P,1_69F(B/<S$=?R90
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M-CA*_,V5EF\RU]8%$DI3,O3 F'&%N80K)WQ0?5>\-7TOVEJ92Q8U:.;N7%#
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M3&\3*7;D(C,[[\C8J/?\>9^WI09+L8-BLS47:C457N#@%1YCJ5& G5.+#:2
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&_P#CU__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
